Chinese Expert Consensus on the Diagnosis and Treatment of Right Heart Failure Caused by Pulmonary Arterial Hypertension
10.3969/j.issn.1000-3614.2025.08.002
- VernacularTitle:动脉型肺动脉高压所致右心衰竭诊治的中国专家共识
- Author:
Changming XIONG
;
Zhihong LIU
- Collective Name:National Center for Cardiovascular Diseases,China Specialized Alliance of Pulmonary Hypertension;National Expert Committee for Cardiovascular Diseases,Professional Committee of Right Heart and Pulmonary Vascular Diseases
- Publication Type:Journal Article
- Keywords:
right heart failure;
pulmonary arterial hypertension;
diagnosis;
treatment;
consensus
- From:
Chinese Circulation Journal
2025;40(8):732-745
- CountryChina
- Language:Chinese
-
Abstract:
Pulmonary arterial hypertension(PAH)is characterized by progressively elevated pulmonary artery pressure and pulmonary vascular resistance.The core pathological consequence is a significant increase in right ventricular afterload,leading to right ventricular-pulmonary arterial uncoupling,and ultimately resulting in right heart failure and death.This consensus was jointly developed by experts in the field,organized by National Center for Cardiovascular Diseases,China Specialized Alliance of Pulmonary Hypertension and National Expert Committee for Cardiovascular Diseases,Professional Committee of Right Heart and Pulmonary Vascular Diseases.The consensus focuses on the definition,classification,epidemiology,pathophysiological mechanisms,diagnosis,assessment,treatment,and management of PAH-induced right heart failure.By the integrating evidence-based medicine data and the clinical expertise of Chinese specialists,this consensus summarizes standardized evaluation and management protocols.Its goals are to enhance the diagnostic and therapeutic standards for PAH-related right heart failure and ultimately improve patients'quality of life while reducing mortality.
